Adaptive Biotechnologies Corp (ADPT)
3.60
-0.12
(-3.23%)
USD |
NASDAQ |
May 20, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
Adaptive Biotechnologies Revenue (Quarterly): 41.87M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 41.87M |
| December 31, 2023 | 45.78M |
| September 30, 2023 | 37.92M |
| June 30, 2023 | 48.93M |
| March 31, 2023 | 37.65M |
| December 31, 2022 | 55.20M |
| September 30, 2022 | 47.83M |
| June 30, 2022 | 43.66M |
| March 31, 2022 | 38.62M |
| December 31, 2021 | 37.93M |
| September 30, 2021 | 39.47M |
| June 30, 2021 | 38.50M |
| March 31, 2021 | 38.44M |
| Date | Value |
|---|---|
| December 31, 2020 | 30.18M |
| September 30, 2020 | 26.30M |
| June 30, 2020 | 20.99M |
| March 31, 2020 | 20.91M |
| December 31, 2019 | 24.21M |
| September 30, 2019 | 26.06M |
| June 30, 2019 | 22.14M |
| March 31, 2019 | 12.67M |
| December 31, 2018 | 17.19M |
| September 30, 2018 | 17.19M |
| June 30, 2018 | 11.57M |
| March 31, 2018 | 9.715M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
20.91M
Minimum
Mar 2020
55.20M
Maximum
Dec 2022
36.13M
Average
38.19M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -47.51M |
| Total Expenses (Quarterly) | 90.64M |
| EPS Diluted (Quarterly) | -0.33 |
| Enterprise Value | 222.98M |
| Gross Profit Margin (Quarterly) | 56.89% |
| Profit Margin (Quarterly) | -113.5% |
| Earnings Yield | -41.39% |
| Normalized Earnings Yield | -41.39 |